7-149719643-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001290187.2(KRBA1):c.110G>A(p.Arg37Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000864 in 1,608,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290187.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRBA1 | NM_001290187.2 | c.110G>A | p.Arg37Gln | missense_variant | 2/17 | ENST00000496259.6 | NP_001277116.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRBA1 | ENST00000496259.6 | c.110G>A | p.Arg37Gln | missense_variant | 2/17 | 1 | NM_001290187.2 | ENSP00000418647 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152020Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000153 AC: 37AN: 241388Hom.: 0 AF XY: 0.000190 AC XY: 25AN XY: 131808
GnomAD4 exome AF: 0.0000906 AC: 132AN: 1456748Hom.: 0 Cov.: 31 AF XY: 0.0000966 AC XY: 70AN XY: 724964
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.5G>A (p.R2Q) alteration is located in exon 2 (coding exon 1) of the KRBA1 gene. This alteration results from a G to A substitution at nucleotide position 5, causing the arginine (R) at amino acid position 2 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at